MRNA (TESLA of biotechnology) towards new highsAfter making a major price correction throughout December, MRNA started in 2021 a new upward movement that is ongoing and leading it to new highs.
Note that
1) the correction was made with a very large volume, which means that the shares left the portfolios of the many and passed into those of the few
2) the RSI has not yet entered the overbought area and
3) it is possible (but perhaps not necessary) to retreat prices close to the previous peak to create a cup-forming handle.
MRNA's upward move is supported by both the expected big sales revenue of its vaccine for Covid-19, and a promising large pipeline of new drugs and vaccines
comprising 27 products under development.
MRNA as well as INO is likely the TESLA of Biotechnology.
Following is presented the short-term trend chart of the stock.
Disclaimer
The author of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only.
It is not an advice or inducement for the purchase or sale of the products mentioned. Before making any investment based on your own personal circumstances,
it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here.
MRNA trade ideas
1/26 WATCHLISTif there is any indication that we are definitely in the final leg of a bull market, today was it. Everything was pumping euphorically at open across the board until the market showed us what a mid-euphoric pullback could look like, with the rug being pulled right from under us. A lot of names like TSLA did bounce back after, but it reminds us that its SUPER IMPORTANT to stay cautious in this environment. I am still bullish in the short term.
1/26 WATCHLIST
My trading style is intraday option trading - these are not swing levels.
MRNA calls over 147.5
BYND calls over 164.15
BYND played out perfectly from the watchlist I posted yesterday. It has a bit more room to go to the next supply at 168.25 and then 171 - let's see if it can keep the momentum up tomorrow
AI calls over 151/152
massive move today. 152 was a support level in December that has turned into resistance that AI has been trying to beat for a month.
TSLA calls over 887 or 900
MSFT calls over 230.2 or 233
Would like to see more tight consolidation underneath these levels but something to keep an eye on for the near future.
BTBT calls over 19
$MRNA - consolidation periodBulls energy was not enough to break out over $130-131 resistance level; though intraday break-outs occurred.
Consolidation continues with retracement to lower $120-115 range.
Entering below the resistance is risky though. And the assumption above of course remains a hypothesis.
Therefore, I'm waiting for confirmation above $132 resistance with bullish momentum telltales.
Fundamentally, MRNA still is targeting $140 and $150 with momentum upside to $160.
$MRNA SWING Moderna has been one of the best traded stock in 2020 , jump from 28 $ to 180 $ then the share price fall to 105$ which is strong support level , Moderna has posted its outlook for vaccine production this year to 600 million Doses , they have outstanding products using the same technology Mrna which proven its efficacy and safety , its no doubt a hone run investments
$MRNA - energy gained to $140 - $150 - $160Classic case of fib level retracements
Target 1: $140
Target 2: $150
Target 3: $160
There are resistance levels to break between the targets.
RSI and MACD suggest there's energy to break towards target #3 prior to earnings.
Considering PEG, future outlook, product pipeline, news storyline and environment - MRNA has a good potential for 2021.
Earnings call will be critical milestone.